+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Glaucoma Treatment Market Research Report by Sales Channel, by Type, by State - United States Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5367981
  • Report
  • July 2021
  • Region: United States
  • 86 pages
  • 360iResearch™
The United States Glaucoma Treatment Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Glaucoma Treatment Market.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Glaucoma Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Sales Channel, the Glaucoma Treatment Market was examined across Hospital Pharmacies, Online Sales, and Retail Pharmacies.
  • Based on Indication, the Glaucoma Treatment Market was examined across Angle Closure Glaucoma, Congenital Glaucoma, Open Angle Glaucoma, and Secondary Glaucoma.
  • Based on Type, the Glaucoma Treatment Market was examined across Alpha Agonist, Beta Blockers, Carbonic Anhydrase Inhibitors, Cholinergic, Combined Medications, and Prostaglandin Analogs.
  • Based on Geography, the Glaucoma Treatment Market was examined across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Glaucoma Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Glaucoma Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Glaucoma Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Glaucoma Treatment Market?
4. What is the competitive strategic window for opportunities in the United States Glaucoma Treatment Market?
5. What are the technology trends and regulatory frameworks in the United States Glaucoma Treatment Market?
6. What is the market share of the leading vendors in the United States Glaucoma Treatment Market?
7. What modes and strategic moves are considered suitable for entering the United States Glaucoma Treatment Market?
Note: Product cover images may vary from those shown
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Sales Channel Outlook
3.4. Indication Outlook
3.5. Type Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges

6. Glaucoma Treatment Market, by Sales Channel
6.1. Introduction
6.2. Hospital Pharmacies
6.3. Online Sales
6.4. Retail Pharmacies

7. Glaucoma Treatment Market, by Indication
7.1. Introduction
7.2. Angle Closure Glaucoma
7.3. Congenital Glaucoma
7.4. Open Angle Glaucoma
7.5. Secondary Glaucoma

8. Glaucoma Treatment Market, by Type
8.1. Introduction
8.2. Alpha Agonist
8.3. Beta Blockers
8.4. Carbonic Anhydrase Inhibitors
8.5. Cholinergic
8.6. Combined Medications
8.7. Prostaglandin Analogs

9. Competitive Landscape
9.1. FPNV Positioning Matrix
9.1.1. Quadrants
9.1.2. Business Strategy
9.1.3. Product Satisfaction
9.2. Market Ranking Analysis
9.3. Market Share Analysis, By Key Player
9.4. Competitive Scenario
9.4.1. Merger & Acquisition
9.4.2. Agreement, Collaboration, & Partnership
9.4.3. New Product Launch & Enhancement
9.4.4. Investment & Funding
9.4.5. Award, Recognition, & Expansion

10. Company Usability Profiles

11. Appendix
11.1. Discussion Guide
11.2. License & Pricing

List of Figures
Figure 1. United States Glaucoma Treatment Market Size, 2020 Vs 2026 (USD Million)
Figure 2. United States Glaucoma Treatment Market Size, by Sales Channel, 2020 (USD Million)
Figure 3. United States Glaucoma Treatment Market Size, by Indication, 2020 (USD Million)
Figure 4. United States Glaucoma Treatment Market Size, by Type, 2020 (USD Million)
Figure 5. United States Glaucoma Treatment Market Size, by Geography, 2020 Vs 2026 (USD Million)
Figure 6. United States Glaucoma Treatment Market Size, 2018-2026 (USD Million)
Figure 7. United States Glaucoma Treatment Market: Market Dynamics
Figure 8. United States Glaucoma Treatment Market Size, by Sales Channel, 2020 Vs 2026 (%)
Figure 9. United States Glaucoma Treatment Market Size, by Sales Channel, 2020 Vs 2026 (USD Million)
Figure 10. Competitive Strategic Window for United States Glaucoma Treatment Market Size, by Sales Channel, 2026
Figure 11. United States Glaucoma Treatment Market Size, by Hospital Pharmacies, 2018-2026 (USD Million)
Figure 12. United States Glaucoma Treatment Market Size, by Hospital Pharmacies, by Geography, 2020 Vs 2026 (USD Million)
Figure 13. United States Glaucoma Treatment Market Size, by Online Sales, 2018-2026 (USD Million)
Figure 14. United States Glaucoma Treatment Market Size, by Online Sales, by Geography, 2020 Vs 2026 (USD Million)
Figure 15. United States Glaucoma Treatment Market Size, by Retail Pharmacies, 2018-2026 (USD Million)
Figure 16. United States Glaucoma Treatment Market Size, by Retail Pharmacies, by Geography, 2020 Vs 2026 (USD Million)
Figure 17. United States Glaucoma Treatment Market Size, by Indication, 2020 Vs 2026 (%)
Figure 18. United States Glaucoma Treatment Market Size, by Indication, 2020 Vs 2026 (USD Million)
Figure 19. Competitive Strategic Window for United States Glaucoma Treatment Market Size, by Indication, 2026
Figure 20. United States Glaucoma Treatment Market Size, by Angle Closure Glaucoma, 2018-2026 (USD Million)
Figure 21. United States Glaucoma Treatment Market Size, by Angle Closure Glaucoma, by Geography, 2020 Vs 2026 (USD Million)
Figure 22. United States Glaucoma Treatment Market Size, by Congenital Glaucoma, 2018-2026 (USD Million)
Figure 23. United States Glaucoma Treatment Market Size, by Congenital Glaucoma, by Geography, 2020 Vs 2026 (USD Million)
Figure 24. United States Glaucoma Treatment Market Size, by Open Angle Glaucoma, 2018-2026 (USD Million)
Figure 25. United States Glaucoma Treatment Market Size, by Open Angle Glaucoma, by Geography, 2020 Vs 2026 (USD Million)
Figure 26. United States Glaucoma Treatment Market Size, by Secondary Glaucoma, 2018-2026 (USD Million)
Figure 27. United States Glaucoma Treatment Market Size, by Secondary Glaucoma, by Geography, 2020 Vs 2026 (USD Million)
Figure 28. United States Glaucoma Treatment Market Size, by Type, 2020 Vs 2026 (%)
Figure 29. United States Glaucoma Treatment Market Size, by Type, 2020 Vs 2026 (USD Million)
Figure 30. Competitive Strategic Window for United States Glaucoma Treatment Market Size, by Type, 2026
Figure 31. United States Glaucoma Treatment Market Size, by Alpha Agonist, 2018-2026 (USD Million)
Figure 32. United States Glaucoma Treatment Market Size, by Alpha Agonist, by Geography, 2020 Vs 2026 (USD Million)
Figure 33. United States Glaucoma Treatment Market Size, by Beta Blockers, 2018-2026 (USD Million)
Figure 34. United States Glaucoma Treatment Market Size, by Beta Blockers, by Geography, 2020 Vs 2026 (USD Million)
Figure 35. United States Glaucoma Treatment Market Size, by Carbonic Anhydrase Inhibitors, 2018-2026 (USD Million)
Figure 36. United States Glaucoma Treatment Market Size, by Carbonic Anhydrase Inhibitors, by Geography, 2020 Vs 2026 (USD Million)
Figure 37. United States Glaucoma Treatment Market Size, by Cholinergic, 2018-2026 (USD Million)
Figure 38. United States Glaucoma Treatment Market Size, by Cholinergic, by Geography, 2020 Vs 2026 (USD Million)
Figure 39. United States Glaucoma Treatment Market Size, by Combined Medications, 2018-2026 (USD Million)
Figure 40. United States Glaucoma Treatment Market Size, by Combined Medications, by Geography, 2020 Vs 2026 (USD Million)
Figure 41. United States Glaucoma Treatment Market Size, by Prostaglandin Analogs, 2018-2026 (USD Million)
Figure 42. United States Glaucoma Treatment Market Size, by Prostaglandin Analogs, by Geography, 2020 Vs 2026 (USD Million)
Figure 43. United States Glaucoma Treatment Market: Fpnv Positioning Matrix
Figure 44. United States Glaucoma Treatment Market: Share, by Key Player, 2020
Figure 45. Competitive Scenario Analysis in United States Glaucoma Treatment Market, by Type

List of Tables
Table 1. United States Glaucoma Treatment Market: Market Segmentation & Coverage
Table 2. United States Dollar Exchange Rate, 2016-2020
Table 3. United States Glaucoma Treatment Market Size, 2018-2026 (USD Million)
Table 4. United States Glaucoma Treatment Market Size, by Sales Channel, 2018-2026 (USD Million)
Table 5. United States Glaucoma Treatment Market Size, by Hospital Pharmacies, by Geography, 2018-2026 (USD Million)
Table 6. United States Glaucoma Treatment Market Size, by Online Sales, by Geography, 2018-2026 (USD Million)
Table 7. United States Glaucoma Treatment Market Size, by Retail Pharmacies, by Geography, 2018-2026 (USD Million)
Table 8. United States Glaucoma Treatment Market Size, by Indication, 2018-2026 (USD Million)
Table 9. United States Glaucoma Treatment Market Size, by Angle Closure Glaucoma, by Geography, 2018-2026 (USD Million)
Table 10. United States Glaucoma Treatment Market Size, by Congenital Glaucoma, by Geography, 2018-2026 (USD Million)
Table 11. United States Glaucoma Treatment Market Size, by Open Angle Glaucoma, by Geography, 2018-2026 (USD Million)
Table 12. United States Glaucoma Treatment Market Size, by Secondary Glaucoma, by Geography, 2018-2026 (USD Million)
Table 13. United States Glaucoma Treatment Market Size, by Type, 2018-2026 (USD Million)
Table 14. United States Glaucoma Treatment Market Size, by Alpha Agonist, by Geography, 2018-2026 (USD Million)
Table 15. United States Glaucoma Treatment Market Size, by Beta Blockers, by Geography, 2018-2026 (USD Million)
Table 16. United States Glaucoma Treatment Market Size, by Carbonic Anhydrase Inhibitors, by Geography, 2018-2026 (USD Million)
Table 17. United States Glaucoma Treatment Market Size, by Cholinergic, by Geography, 2018-2026 (USD Million)
Table 18. United States Glaucoma Treatment Market Size, by Combined Medications, by Geography, 2018-2026 (USD Million)
Table 19. United States Glaucoma Treatment Market Size, by Prostaglandin Analogs, by Geography, 2018-2026 (USD Million)
Table 20. United States Glaucoma Treatment Market: Scores
Table 21. United States Glaucoma Treatment Market: Business Strategy
Table 22. United States Glaucoma Treatment Market: Product Satisfaction
Table 23. United States Glaucoma Treatment Market: Ranking
Table 24. United States Glaucoma Treatment Market: Share, by Key Player, 2020
Table 25. United States Glaucoma Treatment Market: Merger & Acquisition
Table 26. United States Glaucoma Treatment Market: Agreement, Collaboration, & Partnership
Table 27. United States Glaucoma Treatment Market: New Product Launch & Enhancement
Table 28. United States Glaucoma Treatment Market: Investment & Funding
Table 29. United States Glaucoma Treatment Market: Award, Recognition, & Expansion
Table 30. United States Glaucoma Treatment Market: License & Pricing
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll